AN EVALUATION OF THE IOP CHANGES IN PATIENTS SWITCHED FROM BETA BLOCKER MONOTHERAPY OR COMBI-NATION THERAPY TO TRAVATAN IN THE S.T.A.R.T. TRIAL

摘要

Objective: S.T.A.R.T. (Study of Travatan as Replacement Therapy) is an open label, multi-center, prospective, four week trial to evaluate the IOP lowering efficacy of Travatan (travoprost ophthalmic solution, 0.004%) in patients requiring prostaglandin analogue therapy. This analysis reports on patients that were